Path Grand Rounds: Monitoring of residual acute leukemia in the clinical laboratory.
This event has ended.
Brent L. Wood, MD, PhD
Professor, Laboratory Medicine and Pathology
University of Washington
Monitoring of residual acute leukemia in the clinical laboratory.
The enumeration of residual leukemia after therapy is rapidly becoming the standard of care for monitoring response in patients with acute leukemia. This talk will present the current state-of-the-art for flow cytometric and next-generation sequencing approaches to residual disease assessment in acute leukemia and discuss their clinical significance.
Reference PMID: 26668349
After viewing this lecture, attendees should be able to:
1. List the major methods used for laboratory monitoring of residual acute leukemia.
2. Recite the basic principle of immunophenotyping for hematopoietic neoplasms.
3. Describe the advantages and limitations of flow cytometry and NGS for residual disease monitoring.